Actinomycin-D plus 5-(3,3-dimethyl- 1-triazeno)- imidazole-4-carboxamine (DTIC) with or without intravenous corynebacterium parvum in metastatic malignant melanoma
Year: 1982
Type: article
Study design: Clinical Trial
Source: Cancer
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1972417888
